ZA987221B - Method of enhancing bioavailability of fexofenadine and its derivatives - Google Patents
Method of enhancing bioavailability of fexofenadine and its derivativesInfo
- Publication number
- ZA987221B ZA987221B ZA987221A ZA987221A ZA987221B ZA 987221 B ZA987221 B ZA 987221B ZA 987221 A ZA987221 A ZA 987221A ZA 987221 A ZA987221 A ZA 987221A ZA 987221 B ZA987221 B ZA 987221B
- Authority
- ZA
- South Africa
- Prior art keywords
- fexofenadine
- derivatives
- enhancing bioavailability
- bioavailability
- enhancing
- Prior art date
Links
- 230000002708 enhancing effect Effects 0.000 title 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 title 1
- 229960003592 fexofenadine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
- A61K31/75—Polymers of hydrocarbons of ethene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91156397A | 1997-08-14 | 1997-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA987221B true ZA987221B (en) | 1999-02-15 |
Family
ID=25430473
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA987221A ZA987221B (en) | 1997-08-14 | 1998-08-12 | Method of enhancing bioavailability of fexofenadine and its derivatives |
Country Status (29)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT812195E (pt) | 1995-02-28 | 2003-03-31 | Aventis Pharma Inc | Composicao farmaceutica para compostos de piperidinoalcanol |
| UA60335C2 (uk) * | 1997-08-26 | 2003-10-15 | Хехст Маріон Рассел, Інк. | Фармацевтична композиція, яка об'єднує піперидиноалканол з протинабряковим агентом |
| GB9822170D0 (en) * | 1998-10-13 | 1998-12-02 | Danbioyst Uk Ltd | Novel formulations of fexofenadine |
| WO2003101437A2 (en) * | 2002-05-29 | 2003-12-11 | Aventis Pharmaceuticals Holdings Inc. | Method of treating asthma using fexofenadine |
| GB0319935D0 (en) * | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
| AR050043A1 (es) * | 2004-08-03 | 2006-09-20 | Novartis Ag | Metodos para mejorar la biodisponibilidad y composicion farmaceutica para trastornos cardiovasculares |
| JP2008120684A (ja) * | 2005-03-07 | 2008-05-29 | Kumamoto Univ | 抗アレルギー薬 |
| KR101106374B1 (ko) | 2009-06-05 | 2012-01-19 | 민병욱 | 고체연료에 의한 가연성 가스 발생 장치 |
| KR101117014B1 (ko) * | 2009-09-09 | 2012-06-14 | 민병욱 | 부패성 폐기물의 바이오매스 처리에 의한 폐자원 재활용 방법 및 장치 |
| CN101843616B (zh) * | 2010-06-04 | 2011-07-27 | 西安万隆制药有限责任公司 | 一种盐酸非索非那定与微晶纤维素组合物及其制备方法 |
| RU2453315C2 (ru) * | 2010-08-17 | 2012-06-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения аллергических заболеваний |
| EP2709600A1 (en) | 2011-05-20 | 2014-03-26 | Aventis Pharmaceuticals Inc. | Pharmaceutical composition comprising fexofenadine |
| RU2504018C1 (ru) * | 2012-05-28 | 2014-01-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения и социального развития Российской Федерации | Способ моделирования состояния индукции функциональной активности гликопротеина-р финастеридом в эксперименте |
| RU2553362C1 (ru) * | 2014-01-09 | 2015-06-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Способ моделирования состояния ингибирования функциональной активности гликопротеина-р линестренолом в эксперименте |
| CN104188998A (zh) * | 2014-09-18 | 2014-12-10 | 中山大学 | 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| FI900469A7 (fi) * | 1989-01-31 | 1990-08-01 | Ipa Int Pharma Agentur Gmbh | Aktiiviaineita vapauttava systeemi, jonka eroosio on säädetty, ja menetelmä sen valmistamiseksi |
| US5567592A (en) * | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
| JPH11507356A (ja) * | 1995-06-07 | 1999-06-29 | アブマックス，インコーポレイティド | 経口薬理化合物の生物有用性を高めるためのエッセンシャルオイルの利用 |
| WO1996040792A1 (en) * | 1995-06-07 | 1996-12-19 | Novo Nordisk A/S | Modification of polypeptides |
-
1998
- 1998-07-21 DE DE69808303T patent/DE69808303T2/de not_active Expired - Lifetime
- 1998-07-21 PT PT98935892T patent/PT1003528E/pt unknown
- 1998-07-21 WO PCT/US1998/015098 patent/WO1999008690A1/en not_active Ceased
- 1998-07-21 HU HU0003189A patent/HU226823B1/hu unknown
- 1998-07-21 IL IL13452198A patent/IL134521A/xx not_active IP Right Cessation
- 1998-07-21 KR KR10-2000-7001447A patent/KR100522985B1/ko not_active Expired - Lifetime
- 1998-07-21 DK DK98935892T patent/DK1003528T3/da active
- 1998-07-21 EE EEP200000069A patent/EE04263B1/xx unknown
- 1998-07-21 BR BR9811937-0A patent/BR9811937A/pt not_active Application Discontinuation
- 1998-07-21 SK SK184-2000A patent/SK283868B6/sk not_active IP Right Cessation
- 1998-07-21 NZ NZ502133A patent/NZ502133A/xx not_active IP Right Cessation
- 1998-07-21 CN CNB988081598A patent/CN1143680C/zh not_active Expired - Lifetime
- 1998-07-21 CA CA002301267A patent/CA2301267C/en not_active Expired - Lifetime
- 1998-07-21 CZ CZ2000522A patent/CZ293666B6/cs not_active IP Right Cessation
- 1998-07-21 AT AT98935892T patent/ATE224721T1/de active
- 1998-07-21 EP EP98935892A patent/EP1003528B1/en not_active Expired - Lifetime
- 1998-07-21 UA UA2000031425A patent/UA64765C2/uk unknown
- 1998-07-21 ID IDW20000262A patent/ID24463A/id unknown
- 1998-07-21 JP JP2000509429A patent/JP4295913B2/ja not_active Expired - Lifetime
- 1998-07-21 AU AU85050/98A patent/AU725965C/en not_active Expired
- 1998-07-21 ES ES98935892T patent/ES2179523T3/es not_active Expired - Lifetime
- 1998-07-21 PL PL338579A patent/PL191607B1/pl unknown
- 1998-07-21 TR TR2000/00419T patent/TR200000419T2/xx unknown
- 1998-07-21 RU RU2000106042/14A patent/RU2197967C2/ru active
- 1998-08-12 ZA ZA987221A patent/ZA987221B/xx unknown
- 1998-08-13 AR ARP980104005A patent/AR018505A1/es active IP Right Grant
- 1998-11-05 TW TW087113210A patent/TWI240633B/zh not_active IP Right Cessation
-
2000
- 2000-02-09 OA OA1200000032A patent/OA11287A/en unknown
- 2000-02-11 NO NO20000706A patent/NO325148B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL339551A1 (en) | Derivatives of rezorcin | |
| PL339660A1 (en) | Derivatives of amidocarboxylic acids | |
| PL339452A1 (en) | Method of and intermediate products for obtaining antifilanes | |
| IL134521A0 (en) | Method of enhancing bioavailability of fexofenadine and its derivatives | |
| PL340461A1 (en) | Derivatives of isothiazocarboxylic acid | |
| PL329808A1 (en) | Derivatives of indolylpyrrolyden methylpyrrole and method of obtaining them | |
| HUP0002623A3 (en) | Dielectrokinetic sensor and method of its application | |
| PL335163A1 (en) | Method of obtaining substituted thiazolydinodione | |
| PL334769A1 (en) | Derivatives of 5-aroylnaphtene | |
| PL335074A1 (en) | Method of obtaining eprosartane | |
| PL335075A1 (en) | Method of obtaining eprosartane | |
| PL337690A1 (en) | Method of obtaining 4-substituted 1h-indolo-3-glyoxamides | |
| PL334901A1 (en) | Method of obtaining benzothiazolones | |
| PL339188A1 (en) | Method of obtaining oxaphosphorin-2-amines | |
| PL338778A1 (en) | Method of obtaining substitution derivatives of 2-nitroguanidine | |
| PL341358A1 (en) | Method of obtaining paroxetin chlorhydride | |
| ZA985064B (en) | Derivatives of pentaerythrits | |
| PL338777A1 (en) | Derivative of piperidinylmethyloxazolydinone | |
| SI1003528T1 (en) | Method of enhancing bioavailability of fexofenadine and its derivatives | |
| PL340915A1 (en) | Method of obtaining azacycloalkylalkanoyl pseudotetrapeptides | |
| PL335887A1 (en) | Method of obtaining arylaminotriazole pyridines | |
| PL335373A1 (en) | Method of obtaining derivatives of 4h-4-oxoquinolysine-3-carboxylic acid | |
| PL339304A1 (en) | Method of obtaining derivatives of 1-phenylparazolin-3-carboxylic acid | |
| PL336266A1 (en) | Method of obtaining epsilon-caprolactams | |
| PL341302A1 (en) | Method of obtaining chlorobenzoxazoles |